These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3219056)

  • 21. Tumor inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes. Part II: Biological evaluation-in vitro studies on the P 388 D1 leukemia cell line.
    Reile H; Müller R; Gust R; Laske R; Krischke W; Bernhardt G; Spruss T; Jennerwein M; Engel J; Seeber S
    Arch Pharm (Weinheim); 1990 Mar; 323(3):133-40. PubMed ID: 2344259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, chemical characterization and biological evaluation of new platinum (II)-sulfonamide complexes.
    Craciunescu DG; Scarcia V; Furlani A; Parrondo Iglesias E; Ravalico L; Doadrio A
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):183-7. PubMed ID: 2334458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
    Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
    J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In the search for new anticancer drugs. VII. Platinum complexes of diaziridines and azetidine.
    Sosnovsky G; Lukszo J
    J Cancer Res Clin Oncol; 1984; 107(3):217-20. PubMed ID: 6547443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antineoplastic and cytogenetic effects of platinum(II) and palladium(II) complexes with pyridine-2-carboxyaldehyde-thiosemicarbazone.
    Kovala-Demertzi D; Demertzis MA; Varagi V; Papageorgiou A; Mourelatos D; Mioglou E; Iakovidou Z; Kotsis A
    Chemotherapy; 1998; 44(6):421-6. PubMed ID: 9755303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New synthetic route to [bis-1,2-(aminomethyl)benzene]dichloroplatinum(II) complexes, screening for cytotoxic activity in cisplatin-sensitive and resistant human cancer cell lines, and reaction with glutathione.
    Rinke K; Grünert R; Bednarski PJ
    Pharmazie; 2001 Oct; 56(10):763-9. PubMed ID: 11683118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antitumor activities of platinum complexes of unsymmetrical alicyclic diamines as carrier ligands.
    Morikawa K; Honda M; Endoh K; Matsumoto T; Akamatsu K; Mitsui H; Koizumi M
    J Pharm Sci; 1990 Aug; 79(8):750-3. PubMed ID: 2231341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and P-388 antitumor properties of the four diastereomeric 1-hydroxy-3,4-diaminocyclohexane-Cl2PtII complexes.
    Witiak DT; Rotella DP; Wei Y; Filppi JA; Gallucci JC
    J Med Chem; 1989 Jan; 32(1):214-7. PubMed ID: 2909734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes.
    Hrubisko M; Balázová E; Kiss F; Kovácová J; Ujházy V
    Neoplasma; 1989; 36(6):651-7. PubMed ID: 2615869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo and in vitro effectivity of some platinum complexes.
    Balázová E; Hrubisko M; Ujházy V
    Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ring-substituted [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum (II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinoma.
    Karl J; Gust R; Spruss T; Schneider MR; Schönenberger H; Engel J; Wrobel KH; Lux F; Haeberlin ST
    J Med Chem; 1988 Jan; 31(1):72-83. PubMed ID: 3336035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graft; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplat inum (II) inhibits this process.
    Schlemmer R; Spruss T; Bernhardt G; Schönenberger H
    Arch Pharm (Weinheim); 2000 Mar; 333(2-3):69-71. PubMed ID: 10783521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antineoplastic and cytogenetic effects of complexes of Pd (II) with 4N-substituted derivatives of 2-acetyl-pyridine-thiosemicarbazone.
    Papageorgiou A; Iakovidou Z; Mourelatos D; Mioglou E; Boutis L; Kotsis A; Kovala-Demertzi D; Domopoulou A; West DX; Dermetzis MA
    Anticancer Res; 1997; 17(1A):247-51. PubMed ID: 9066660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the synthesis, cytostatic and antitumor properties of new Pt(II) and Pt(IV) complexes with chloroanilines.
    Craciunescu DG; Furlani A; Scarcia V; Ghirvu C; Doadrio A
    Chem Biol Interact; 1985; 53(1-2):45-56. PubMed ID: 3995655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [DL-1,2-bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer.
    Müller R; Gust R; Bernhardt G; Keller C; Schönenberger H; Seeber S; Osieka R; Eastman A; Jennerwein M
    J Cancer Res Clin Oncol; 1990; 116(3):237-44. PubMed ID: 2370248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of the conformational influences on the estrogenic activity of 1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines and of their platinum(II) complexes, II: Synthesis and studies on the estrogenic activity of cis- and trans[bis(2,6-dichloro-4-hydroxybenzylamine)]dihaloplatinum(II)-c omplexes.
    Gust R; Schönenberger H
    Arch Pharm (Weinheim); 1994 Dec; 327(12):763-9. PubMed ID: 7872853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA-directed alkylating agents. 5. Acridinecarboxamide derivatives of (1,2-diaminoethane)dichloroplatinum(II).
    Lee HH; Palmer BD; Baguley BC; Chin M; McFadyen WD; Wickham G; Thorsbourne-Palmer D; Wakelin LP; Denny WA
    J Med Chem; 1992 Aug; 35(16):2983-7. PubMed ID: 1501223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [N-ethyl- and [N,N'-diethyl-1,2-bis(2,6-difluoro-3-hydroxyphenyl)-ethylenediamine]dichloroplatinum(II): structure and cytotoxic/estrogenic activity in breast cancer cells.
    Gust R; Niebler K; Schönenberger H
    J Med Chem; 2005 Nov; 48(23):7132-44. PubMed ID: 16279771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxorubicin 14-ethers.
    Masi P; Suarato A; Giardino P; Bernardi L; Arcamone F
    Farmaco Sci; 1979 Oct; 34(10):907-13. PubMed ID: 510533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation, characterization, and anticancer activity of a series of cis-PtCl2 complexes linked to anthraquinone intercalators.
    Gibson D; Gean KF; Ben-Shoshan R; Ramu A; Ringel I; Katzhendler J
    J Med Chem; 1991 Jan; 34(1):414-20. PubMed ID: 1992142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.